These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21725901)

  • 1. Role of cerebrospinal fluid and plasma biomarkers in the diagnosis of neurodegenerative disorders and mild cognitive impairment.
    Gonzalez-Cuyar LF; Sonnen JA; Montine KS; Keene CD; Montine TJ
    Curr Neurol Neurosci Rep; 2011 Oct; 11(5):455-63. PubMed ID: 21725901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid biomarkers in mild cognitive impairment and dementia.
    Sonnen JA; Montine KS; Quinn JF; Breitner JC; Montine TJ
    J Alzheimers Dis; 2010; 19(1):301-9. PubMed ID: 20061646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal Fluid and Plasma Biomarkers in Neurodegenerative Diseases.
    Seino Y; Nakamura T; Kawarabayashi T; Hirohata M; Narita S; Wakasaya Y; Kaito K; Ueda T; Harigaya Y; Shoji M
    J Alzheimers Dis; 2019; 68(1):395-404. PubMed ID: 30814356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies.
    Mattsson-Carlgren N; Palmqvist S; Blennow K; Hansson O
    Nat Commun; 2020 Dec; 11(1):6252. PubMed ID: 33288742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment.
    Hu WT; Chen-Plotkin A; Arnold SE; Grossman M; Clark CM; Shaw LM; Pickering E; Kuhn M; Chen Y; McCluskey L; Elman L; Karlawish J; Hurtig HI; Siderowf A; Lee VM; Soares H; Trojanowski JQ
    Acta Neuropathol; 2010 Jun; 119(6):669-78. PubMed ID: 20232070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurochemical markers of neurodegeneration in the early diagnosis of Alzheimer's disease, vascular and mixed dementia].
    Uspenskaia OV; Iakhno NN; Belushkina NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(8):36-40. PubMed ID: 20823828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.
    Lewczuk P; Riederer P; O'Bryant SE; Verbeek MM; Dubois B; Visser PJ; Jellinger KA; Engelborghs S; Ramirez A; Parnetti L; Jack CR; Teunissen CE; Hampel H; Lleó A; Jessen F; Glodzik L; de Leon MJ; Fagan AM; Molinuevo JL; Jansen WJ; Winblad B; Shaw LM; Andreasson U; Otto M; Mollenhauer B; Wiltfang J; Turner MR; Zerr I; Handels R; Thompson AG; Johansson G; Ermann N; Trojanowski JQ; Karaca I; Wagner H; Oeckl P; van Waalwijk van Doorn L; Bjerke M; Kapogiannis D; Kuiperij HB; Farotti L; Li Y; Gordon BA; Epelbaum S; Vos SJB; Klijn CJM; Van Nostrand WE; Minguillon C; Schmitz M; Gallo C; Lopez Mato A; Thibaut F; Lista S; Alcolea D; Zetterberg H; Blennow K; Kornhuber J;
    World J Biol Psychiatry; 2018 Jun; 19(4):244-328. PubMed ID: 29076399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
    Wilcock D; Jicha G; Blacker D; Albert MS; D'Orazio LM; Elahi FM; Fornage M; Hinman JD; Knoefel J; Kramer J; Kryscio RJ; Lamar M; Moghekar A; Prestopnik J; Ringman JM; Rosenberg G; Sagare A; Satizabal CL; Schneider J; Seshadri S; Sur S; Tracy RP; Yasar S; Williams V; Singh H; Mazina L; Helmer KG; Corriveau RA; Schwab K; Kivisäkk P; Greenberg SM;
    Alzheimers Dement; 2021 Apr; 17(4):704-715. PubMed ID: 33480172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Dutch Parelsnoer Institute--Neurodegenerative diseases; methods, design and baseline results.
    Aalten P; Ramakers IH; Biessels GJ; de Deyn PP; Koek HL; OldeRikkert MG; Oleksik AM; Richard E; Smits LL; van Swieten JC; Teune LK; van der Lugt A; Barkhof F; Teunissen CE; Rozendaal N; Verhey FR; van der Flier WM
    BMC Neurol; 2014 Dec; 14():254. PubMed ID: 25551191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal Fluid and MRI Biomarkers in Neurodegenerative Diseases: A Retrospective Memory Clinic-Based Study.
    Kaipainen A; Jääskeläinen O; Liu Y; Haapalinna F; Nykänen N; Vanninen R; Koivisto AM; Julkunen V; Remes AM; Herukka SK
    J Alzheimers Dis; 2020; 75(3):751-765. PubMed ID: 32310181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-beta plasma and cerebrospinal fluid biomarkers in aged dogs with cognitive dysfunction syndrome.
    Stylianaki I; Polizopoulou ZS; Theodoridis A; Koutouzidou G; Baka R; Papaioannou NG
    J Vet Intern Med; 2020 Jul; 34(4):1532-1540. PubMed ID: 32557873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg.
    Obrocki P; Khatun A; Ness D; Senkevich K; Hanrieder J; Capraro F; Mattsson N; Andreasson U; Portelius E; Ashton NJ; Blennow K; Schöll M; Paterson RW; Schott JM; Zetterberg H
    Alzheimers Res Ther; 2020 Feb; 12(1):20. PubMed ID: 32111242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofilament Light Chain in Cerebrospinal Fluid and Blood as a Biomarker for Neurodegenerative Diseases: A Systematic Review and Meta-Analysis.
    Wang SY; Chen W; Xu W; Li JQ; Hou XH; Ou YN; Yu JT; Tan L
    J Alzheimers Dis; 2019; 72(4):1353-1361. PubMed ID: 31744001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of cerebrospinal fluid (CSF) biomarkers for Alzheimer's type dementia: diagnosis in mild cognitive impairment].
    Verhey FR; Visser PJ
    Ned Tijdschr Geneeskd; 2013; 157(11):A5596. PubMed ID: 23484512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists?
    Eratne D; Loi SM; Walia N; Farrand S; Li QX; Varghese S; Walterfang M; Evans A; Mocellin R; Dhiman K; Gupta V; Malpas CB; Collins S; Masters CL; Velakoulis D
    Aust N Z J Psychiatry; 2020 Jan; 54(1):57-67. PubMed ID: 31220922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in cerebrospinal fluid for synucleinopathies, tauopathies, and other neurodegenerative disorders.
    Marques TM; Van Rumund A; Kuiperij HB; Verbeek MM
    Handb Clin Neurol; 2017; 146():99-113. PubMed ID: 29110782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.
    Noelker C; Hampel H; Dodel R
    Mol Diagn Ther; 2011 Apr; 15(2):83-102. PubMed ID: 21623645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer's disease biomarker related cognitive decline?
    Ye BS; Lee WW; Ham JH; Lee JJ; Lee PH; Sohn YH;
    Eur J Neurol; 2016 May; 23(5):948-57. PubMed ID: 26917248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Ritchie C; Smailagic N; Noel-Storr AH; Takwoingi Y; Flicker L; Mason SE; McShane R
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD008782. PubMed ID: 24913723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.